These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37429430)

  • 1. Anticoagulation use is associated with lower fetal fraction and more indeterminate results.
    Shree R; MacKinnon HJ; Hannan J; Kolarova TR; Reichel J; Lockwood CM
    Am J Obstet Gynecol; 2024 Jan; 230(1):95.e1-95.e10. PubMed ID: 37429430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of maternal autoimmune disease on cell-free DNA test characteristics.
    MacKinnon HJ; Kolarova TR; Katz R; Hedge JM; Vinopal E; Lockwood CM; Shree R; Delaney S
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100466. PubMed ID: 34418590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of heparin, aspirin, and maternal clinical factors on the rate of nonreportable cell-free DNA results: a retrospective cohort study.
    Nitsche JF; Lovell D; Stephens N; Conrad S; Bebeau K; Brost BC
    Am J Obstet Gynecol MFM; 2023 Mar; 5(3):100846. PubMed ID: 36572105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity.
    Shree R; Kolarova TR; MacKinnon HJ; Lockwood CM; Chandrasekaran S
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100671. PubMed ID: 35644526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
    Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
    Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
    Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
    Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA.
    Shree R; Kolarova TR; MacKinnon HJ; Hedge JM; Vinopal E; Ma KK; Lockwood CM; Chandrasekaran S
    Prenat Diagn; 2021 Sep; 41(10):1277-1286. PubMed ID: 34297415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A statistical investigation of parameters associated with low cell-free fetal DNA fraction in maternal plasma for noninvasive prenatal testing.
    Pan Y; Pan X; Zhuang D; Zhou Y; Xue J; Wu S; Chen C; Li H
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2338440. PubMed ID: 38604949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies.
    Bellai-Dussault K; Meng L; Howley H; Reszel J; Huang T; Lanes A; Walker MC; Okun N; Dougan SD; Armour CM
    Am J Obstet Gynecol; 2023 Aug; 229(2):168.e1-168.e8. PubMed ID: 36627072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free fetal DNA testing performance and fetal fraction estimation are not affected in ART-conceived pregnancies.
    Balaguer N; Mateu-Brull E; Gómez-López M; Simón C; Milán M
    Hum Reprod; 2022 Nov; 37(12):2743-2756. PubMed ID: 36223600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results.
    Norton ME; MacPherson C; Demko Z; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Strong N; Haeri S; Silver R; Vohra N; Hyett J; Martin K; Rabinowitz M; Jacobsson B; Dar P
    Am J Obstet Gynecol; 2023 Sep; 229(3):300.e1-300.e9. PubMed ID: 36965866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women.
    Becking EC; Scheffer PG; Henrichs J; Bax CJ; Crombag NMTH; Weiss MM; Macville MVE; Van Opstal D; Boon EMJ; Sistermans EA; Henneman L; Schuit E; Bekker MN
    Am J Obstet Gynecol; 2024 Aug; 231(2):244.e1-244.e18. PubMed ID: 38097030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cell-free DNA fetal fraction and gestational diabetes.
    Hopkins MK; Koelper N; Bender W; Durnwald C; Sammel M; Dugoff L
    Prenat Diagn; 2020 May; 40(6):724-727. PubMed ID: 32091624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fetal fraction enrichment method reduces false negatives and increases test success rate of fetal chromosome aneuploidy detection in early pregnancy loss.
    Qiao L; Zhang B; Wu X; Zhang C; Xue Y; Tang H; Tang H; Shi J; Liang Y; Yu B; Wang T
    J Transl Med; 2022 Aug; 20(1):345. PubMed ID: 35918754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.
    Creswell L; Doddy F; Manning C; Nazir SF; Lindow SW; Lynch C; O'Gorman N
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():143-149. PubMed ID: 37797414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):e31-e37. PubMed ID: 26287791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.